{"id":233160,"date":"2026-09-07T12:40:13","date_gmt":"2026-09-07T07:10:13","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=233160"},"modified":"2026-09-07T12:40:15","modified_gmt":"2026-09-07T07:10:15","slug":"is-akums-drugs-and-pharmaceuticals-a-good-buy-after-q1-fy27-results","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/is-akums-drugs-and-pharmaceuticals-a-good-buy-after-q1-fy27-results\/","title":{"rendered":"Is Akums Drugs and Pharmaceuticals a Good Buy After Its Q1 FY27 Results?"},"content":{"rendered":"

Akums Drugs and Pharmaceuticals share price around Rs 759. 4.7% below 52-week high of Rs 797. Q1 FY27 revenue Rs 1,197 crore, up 13.9% YoY. PAT Rs 101 crore, up 56.1%. PE 41x.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Akums Drugs and Pharmaceuticals’ Q1 FY27 results were strong, with revenue at Rs 1,197 crore and PAT climbing 56% to Rs 101 crore. The stock trades at a PE of 41x against an industry average near 38x, so some of this good news is already priced in. The Akums Drugs and Pharmaceuticals share price near Rs 759 reflects that optimism, so investors weighing whether Akums Drugs and Pharmaceuticals is a good buy today should focus on whether this pace of growth can be sustained rather than just this quarter’s print.<\/p>\n<\/div>\n

The Akums Drugs and Pharmaceuticals share price has been under the spotlight this results season after the company reported its first-quarter numbers for FY27. Akums Drugs and Pharmaceuticals is one of India’s largest pharmaceutical CDMOs, manufacturing formulations for other drugmakers, and its Q1 FY27 print, for the quarter ended June 30, 2026, gives investors a fresh data point to test whether the stock still deserves a place in a portfolio at current levels.<\/p>\n

Revenue for the quarter came in at Rs 1,197 crore, up 13.9% year on year, while profit after tax came in at Rs 101 crore, up 56.1% from a year earlier. That combination of numbers is exactly what this article breaks down, along with what it means for the Akums Drugs and Pharmaceuticals share price from here.<\/p>\n

This piece works through the quarter’s financial highlights, the business factors behind the numbers, where the Akums Drugs and Pharmaceuticals share price stands against its 52-week range and valuation multiples, and the key risks worth watching before treating this as a buy, hold or a stock to avoid for now.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n